U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup said on Wednesday, to develop and commercialize treatments for hearing loss ...

Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid ...

Intellia Therapeutics stock surged Tuesday after the FDA aid it would allow the company to restart a gene-editing study.

CRISPR therapy STX-1150 could replace daily cholesterol pills with a single dose, reducing LDL by 50% for 18+ months using ...

A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...

Intellia is instituting new safeguards following the death of a study participant that led regulators to pause two trials in ...

Caffeine could act as an on-off switch for gene and cell therapies, giving doctors more precise control over powerful ...

In November, six months after KJ’s debut, top Food and Drug Administration officials Marty Makary and Vinay Prasad published ...

Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

Inari, a seed gene-editing company with facilities in Purdue Research Park, filed notice with the Indiana Department of ...